Bayforest Capital Ltd has sharply reduced its stake in Bio-Rad Laboratories, Inc., selling 194 shares during the first quarter. The latest regulatory filing confirms a 53.2% decrease in the company’s holdings of the medical research firm.
Hancock Whitney Corp significantly reduced its stake in Agilent Technologies by 71.9% in the first quarter. According to new SEC filings, the fund sold 7,562 shares and now holds 2,951 shares of the medical research company.
The State of Wyoming grew its position in Charles River Laboratories International, Inc. by 16.5% during the first quarter. Official reports show the state acquired 208 additional shares, bringing its total holdings to 1,468 shares in the medical research company.
1248 Management LLC has initiated a new stake in Thermo Fisher Scientific valued at $130,000, acquiring 261 shares in the first quarter. This position, disclosed in a filing with the SEC, underscores 1248 Management’s interest in the medical research sector.
Ameriprise Financial Inc. has significantly expanded its stake in RadNet, Inc. by purchasing nearly half a million shares in the first quarter, bringing its total holdings to over three-quarters of a million. This move highlights growing confidence in RadNet’s role as a medical research company.
A new study reveals that Millennials and Gen X are three times more likely than their parents to be diagnosed with appendix cancer, leaving experts searching for answers. The alarming rise of this rare cancer among younger generations has puzzled the medical community and highlighted a forgotten disease.
Microplastics have been discovered in the large neck arteries that supply blood to the brain, with stroke survivors showing the highest levels of accumulation, according to a recent small study.
With few effective treatments available for amyotrophic lateral sclerosis, the ashwagandha plant emerges as a beacon of hope for patients battling this debilitating disease. Could this ancient remedy provide relief where modern medicine has struggled?
